Explore
← New search
Filters:
discrepant
✕
University of Lausanne
✕
b16-ova, mc38-ova, and b16-f10 tumor-bearing mice (ot1 and pmel act)
✕
clear all
1 matching publication(s)
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells.
PMID 37081150 · Nat Immunol · 2023
L1
37/100